BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao H, Zheng Y, Ma L, Tian L, Sun Q. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance. Front Pharmacol 2021;12:648407. [PMID: 33953682 DOI: 10.3389/fphar.2021.648407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Elisabetta G, Anna B, Adriano P, Andrea CD, Guido S, Ilaria P, Andrea B, Lorenzo A, Serena P. Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity. Cancer Treat Res Commun 2022;31:100528. [PMID: 35123198 DOI: 10.1016/j.ctarc.2022.100528] [Reference Citation Analysis]
2 Wei Y, Amend B, Todenhöfer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. Int J Mol Sci 2022;23:6305. [PMID: 35682984 DOI: 10.3390/ijms23116305] [Reference Citation Analysis]
3 Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sharma N, Bietar K, Stochaj U. Targeting nanoparticles to malignant tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188703] [Reference Citation Analysis]
5 Rizwanullah M, Ahmad MZ, Ghoneim MM, Alshehri S, Imam SS, Md S, Alhakamy NA, Jain K, Ahmad J. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics 2021;13:2039. [PMID: 34959321 DOI: 10.3390/pharmaceutics13122039] [Reference Citation Analysis]
6 Liu Y, Xia H, Wang Y, Han W, Qin J, Gao W, Qu X, Wang X. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro. Thorac Cancer 2021;12:3053-61. [PMID: 34617400 DOI: 10.1111/1759-7714.14182] [Reference Citation Analysis]
7 Ohya S, Kajikuri J, Endo K, Kito H, Matsui M. KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model. Int J Mol Sci 2021;22:13553. [PMID: 34948357 DOI: 10.3390/ijms222413553] [Reference Citation Analysis]
8 Mosca L, Pagano M, Borzacchiello L, Mele L, Russo A, Russo G, Cacciapuoti G, Porcelli M. S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation. Int J Mol Sci 2021;22:9286. [PMID: 34502219 DOI: 10.3390/ijms22179286] [Reference Citation Analysis]
9 Ma L, Lei J, Chen H, Huang R, Su T, Feng J, Sun Q. Structural insight into SSE15206 in complex with tubulin provides a rational design for pyrazolinethioamides as tubulin polymerization inhibitors. Future Med Chem 2022. [PMID: 35506429 DOI: 10.4155/fmc-2021-0124] [Reference Citation Analysis]
10 Gericke B, Wienböker I, Brandes G, Löscher W. Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver. Cells 2022;11:1556. [DOI: 10.3390/cells11091556] [Reference Citation Analysis]
11 Wu ZX, Yang Y, Wang JQ, Narayanan S, Lei ZN, Teng QX, Zeng L, Chen ZS. Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor. Front Cell Dev Biol 2021;9:697927. [PMID: 34336849 DOI: 10.3389/fcell.2021.697927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Reddi KK, Guruvaiah P, Edwards YJK, Gupta R. Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells. Front Oncol 2022;12:937831. [DOI: 10.3389/fonc.2022.937831] [Reference Citation Analysis]
13 Ding Y, Zhen Z, Nisar MA, Ali F, Din RU, Khan M, Mughal TA, Alam G, Liu L, Saleem MZ. Sesquiterpene Lactones Attenuate Paclitaxel Resistance Via Inhibiting MALAT1/STAT3/ FUT4 Axis and P-Glycoprotein Transporters in Lung Cancer Cells. Front Pharmacol 2022;13:795613. [PMID: 35281907 DOI: 10.3389/fphar.2022.795613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Teng YN, Chen LH, Chen Kui Vavulengan YH. Repositioning application of polyoxyethylene (20) sorbitan monooleate on ocular drug resistance and cancer multi-drug resistance by inhibiting the ATPase activity of human multidrug resistance protein 1 and P-glycoprotein. Eur J Pharm Biopharm 2021:S0939-6411(21)00351-9. [PMID: 34896572 DOI: 10.1016/j.ejpb.2021.12.002] [Reference Citation Analysis]
15 Di Fiore R, Suleiman S, Drago-Ferrante R, Subbannayya Y, Pentimalli F, Giordano A, Calleja-Agius J. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. Int J Mol Sci 2022;23:5167. [PMID: 35563557 DOI: 10.3390/ijms23095167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pavlíková L, Šereš M, Breier A, Sulová Z. The Roles of microRNAs in Cancer Multidrug Resistance. Cancers (Basel) 2022;14:1090. [PMID: 35205839 DOI: 10.3390/cancers14041090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu Y, Wang Y, Li X, Jia Y, Wang J, Ao X. FOXO3a in cancer drug resistance. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215724] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nurcahyanti ADR, Kusmita L, Wink M. Bixin and fucoxanthin sensitize human lung cancer and cervical cancer cell to cisplatin in vitro. BMC Res Notes 2021;14:454. [PMID: 34922615 DOI: 10.1186/s13104-021-05866-4] [Reference Citation Analysis]
19 Basak D, Arrighi S, Darwiche Y, Deb S. Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life (Basel) 2021;12:48. [PMID: 35054441 DOI: 10.3390/life12010048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kusmita L, Franyoto YD, Mutmainah M, Puspitaningrum I, Nurcahyanti ADR. Bixa orellana L. carotenoids: antiproliferative activity on human lung cancer, breast cancer, and cervical cancer cells in vitro. Nat Prod Res 2022;:1-7. [PMID: 35133226 DOI: 10.1080/14786419.2022.2036144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zheng YB, Dong YQ, Si SY, Zhen YS, Gong JH. IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors. Eur J Pharmacol 2022;:174802. [PMID: 35143830 DOI: 10.1016/j.ejphar.2022.174802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cardoso DSP, Szemerédi N, Spengler G, Mulhovo S, Dos Santos DJVA, Ferreira MU. Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer. Pharmaceuticals (Basel) 2021;14:862. [PMID: 34577562 DOI: 10.3390/ph14090862] [Reference Citation Analysis]
23 Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]
24 Xiao Q, Koutsilieri S, Sismanoglou DC, Lauschke VM. CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers. J Cancer Res Clin Oncol 2022. [PMID: 35715537 DOI: 10.1007/s00432-022-04106-x] [Reference Citation Analysis]